Becton, Dickinson and Co. | BDX - Operating Expenses

Stock Price
185.39
Daily Change
2.92 1.60%
Monthly
-10.08%
Yearly
-18.48%
Q1 Forecast
179.64

Becton, Dickinson and Co. reported $4.59B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Agilent USD 1.42B 57M Sep/2025
Align Technology USD 822.85M 11.8M Dec/2025
AngioDynamics USD 81.98M 1.96M Feb/2025
Avanos Medical USD 158.83M 69.83M Sep/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Boston Scientific USD 4.04B 18M Dec/2025
Cooper Companies USD 924.8M 40.2M Sep/2025
Danaher USD 5.34B 45.74B Dec/2025
Dentsply International USD 1.48B 653M Sep/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Exact Sciences USD 875.74M 62.51M Sep/2025
Globus Medical USD 886.57M 730.06M Sep/2025
Hologic USD 349.4M 447.1M Dec/2025
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 1.04B 620.66M Sep/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Masimo USD 147M 159.4M Sep/2025
Medtronic USD 7.28B 16M Dec/2025
Solventum Corp USD 4.99B 3.04B Sep/2025
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 3.82B 3.22B Sep/2025
Terumo JPY 252.74B 22.88B Dec/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025